Marina Beraza-Millor

mRNA-Based Nanomedicinal Products to Address Corneal Inflammation by Interleukin-10 Supplementation

L. Battaglia, A. Rodríguez-Gascón, M. Solinís, 2021, Pharmaceutics.

Galactomannan-Decorated Lipidic Nanocarrier for Gene Supplementation Therapy in Fabry Disease

A. Rodríguez-Gascón, M. Solinís, A. Del Pozo-Rodríguez, 2022, Nanomaterials.

mRNA delivery technologies: Toward clinical translation.

A. Rodríguez-Gascón, M. Solinís, A. Del Pozo-Rodríguez, 2022, International review of cell and molecular biology.

Novel Golden Lipid Nanoparticles with Small Interference Ribonucleic Acid for Substrate Reduction Therapy in Fabry Disease

J. Miranda, A. Rodríguez-Gascón, M. Solinís, 2023, Pharmaceutics.

Targeting strategies with lipid vectors for nucleic acid supplementation therapy in Fabry disease: a systematic review

A. Rodríguez-Gascón, Marina Beraza-Millor, Julen Rodríguez-Castejón, 2024, Drug delivery and translational research.

Systematic Review of Genetic Substrate Reduction Therapy in Lysosomal Storage Diseases: Opportunities, Challenges and Delivery Systems

A. Rodríguez-Gascón, A. Del Pozo-Rodríguez, Julen Rodríguez-Castejón, 2024, BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy.

Gene therapy with lipid nanoparticles for Fabry disease: Leveraging E-selectin for targeted delivery to endothelial cells

J. Plantinga, A. Rodríguez-Gascón, Marina Beraza-Millor, 2024, Journal of Drug Delivery Science and Technology.